Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 3 open reading frame 80 (C3orf80) encodes a predicted single-pass membrane protein of 247 amino acids, found mainly at the cell membrane, with enriched expression in the cerebral cortex, esophagus, colon, and ciliated glandular cells of the human fallopian tube[1]. The protein is largely uncharacterized, with no known enzymatic or receptor activity, and its molecular function and involvement in human disease remain unclear. Some studies associate its expression with various cancers and immune system-related tissue responses, including higher expression in multiple sclerosis lesions and as a component of biomarker panels for cancer prognosis and chemotherapy response[1]. C3orf80 appears to be evolutionarily conserved among vertebrates[1][7]. There is currently no evidence that C3orf80 is an established drug target or has known interacting drugs[7][1]. Proposed immune-regulatory or enzymatic functions described for related proteins in some sources may represent confusion with other membrane ecto-enzymes rather than experimentally validated features of C3orf80 itself[3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 3 open reading frame 80 (C3orf80).